Amneal Pharmaceuticals (AMRX) total assets

Total assets · fiscal 2025
$3.68B

Amneal Pharmaceuticals (AMRX) had total assets of $3.68B at the end of fiscal 2025 (December 31, 2025). That is 5.1% higher than the $3.50B of fiscal 2024. Figures as of 18 Nov 2026, 04:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$3.68B
Change on fiscal 2024
+5.1%
Growth, 5 years
−1.7% a year
Highest on record
$4.35Bfiscal 2018
Lowest on record
$1.34Bfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amneal Pharmaceuticals total assets, in more detail

Over the five fiscal years to 2025 total assets shrank at a compound 1.7% a year. Across the 9 fiscal years on record (2017–2025), the highest was $4.35B in fiscal 2018 and the lowest $1.34B in fiscal 2017.

History · 9 fiscal years

Total assets by fiscal year

Amneal Pharmaceuticals total assets, year by year

Amneal Pharmaceuticals (AMRX) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$3.68B 5.1% up
2024$3.50B 0.8% up
2023$3.47B 8.6% down
2022$3.80B 3.6% down
2021$3.94B 1.7% down
2020$4.01B 9.3% up
2019$3.67B 15.8% down
2018$4.35B 224.4% up
2017$1.34B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Amneal Pharmaceuticals and comparable companies
CompanyTotal assetsFiscal year
Cytokinetics CYTK$1.42B2025
ABIVAX ABVX€584.34M2025
Bausch + Lomb BLCO$14.02B2025
Amneal Pharmaceuticals AMRX$3.68B2025
Caris Life Sciences CAI$1.13B2025
Immunovant IMVT$957.01M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMRX

Amneal Pharmaceuticals, figure by figure

Amneal Pharmaceuticals (AMRX) overview: price, valuation and scorecardAll health care companies by market value

Amneal Pharmaceuticals total assets: questions and answers

How large are Amneal Pharmaceuticals's total assets?

Amneal Pharmaceuticals (AMRX) had total assets of $3.68B at the end of fiscal 2025 (December 31, 2025). That is 5.1% higher than the $3.50B of fiscal 2024.

What is the growth rate of Amneal Pharmaceuticals's total assets?

Over the five fiscal years to 2025 total assets shrank at a compound 1.7% a year.

What are the highest and lowest total assets figures on record for Amneal Pharmaceuticals?

Across the 9 fiscal years on record (2017–2025), the highest was $4.35B in fiscal 2018 and the lowest $1.34B in fiscal 2017.

How is Amneal Pharmaceuticals's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amneal Pharmaceuticals (AMRX) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/AMRX/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.